ALKS
Alkermes Plc
Price:  
27.39 
USD
Volume:  
2,140,816.00
Ireland | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Alkermes EV/EBITDA

-8.2%
Upside

As of 2025-09-16, the EV/EBITDA ratio of Alkermes Plc (ALKS) is 9.83. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Alkermes's latest enterprise value is 4,000.34 mil USD. Alkermes's TTM EBITDA according to its financial statements is 406.81 mil USD. Dividing these 2 quantities gives us the above Alkermes EV/EBITDA ratio.

Range Selected
Trailing P/E multiples 9.2x - 9.8x 9.5x
Forward P/E multiples 6.5x - 9.2x 7.8x
Fair Price 20.19 - 27.31 25.15
Upside -26.3% - -0.3% -8.2%
27.39 USD
Stock Price
25.15 USD
Fair Price

Alkermes EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2025-09-12 9.66
2025-09-11 9.96
2025-09-10 9.65
2025-09-09 10.02
2025-09-08 10.26
2025-09-05 10.87
2025-09-04 10.45
2025-09-03 10.89
2025-09-02 10.65
2025-08-29 10.47
2025-08-28 10.46
2025-08-27 10.59
2025-08-26 10.48
2025-08-25 10.49
2025-08-22 10.79
2025-08-21 10.51
2025-08-20 10.47
2025-08-19 10.43
2025-08-18 10.13
2025-08-15 10.51
2025-08-14 10.19
2025-08-13 10.34
2025-08-12 9.85
2025-08-11 9.49
2025-08-08 9.56
2025-08-07 9.51
2025-08-06 9.49
2025-08-05 9.51
2025-08-04 9.53
2025-08-01 9.49
2025-07-31 9.47
2025-07-30 10.05
2025-07-29 9.68
2025-07-28 9.33
2025-07-25 9.32
2025-07-24 9.48
2025-07-23 9.75
2025-07-22 9.69
2025-07-21 9.54
2025-07-18 10.58
2025-07-17 10.63
2025-07-16 10.57
2025-07-15 10.43
2025-07-14 10.77
2025-07-11 11.01
2025-07-10 11.08
2025-07-09 10.88
2025-07-08 10.64
2025-07-07 10.58
2025-07-03 10.43